SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Susan E. Tett, Ingrid Sketris, Charmaine Cooke, Sander Veldhuyzen Zanten, Nadia Barozzi, Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada, Pharmacoepidemiology and Drug Safety, 2013, 22, 7
  2. You have free access to this content2
    M. Schmidt, M. B. Johansen, D. J. Robertson, M. Maeng, A. Kaltoft, L. O. Jensen, H.-H. Tilsted, H. E. Bøtker, H. T. Sørensen, J. A. Baron, Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation, Alimentary Pharmacology & Therapeutics, 2012, 35, 1
  3. 3
    Michael Schiff, David Peura, HZT-501 (DUEXIS®; ibuprofen 800 mg/famotidine 26.6 mg) gastrointestinal protection in the treatment of the signs and symptoms of rheumatoid arthritis and osteoarthritis, Expert Review of Gastroenterology & Hepatology, 2012, 6, 1, 25

    CrossRef

  4. 4
    Yanushi Dullewe Wijeyeratne, Rashi Joshi, Stan Heptinstall, Ticagrelor: a P2Y12antagonist for use in acute coronary syndromes, Expert Review of Clinical Pharmacology, 2012, 5, 3, 257

    CrossRef